Actinium Pharma (ATNM) to Provide Update on Pivotal Phase 3 SIERRA Trial Following Positive DMC Meeting
Tweet Send to a Friend
Actinium Pharmaceuticals, Inc. (NYSE: ATNM) , today announced that it will conduct a conference call on Wednesday, August 15 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
